T endons are the small but tough linkers between bones and muscle. When they are injured, repairing a tendon is no small task ...
The FDA has granted a groundbreaking approval to Humacyte for its off-the-shelf, bioengineered blood vessel implant, designed ...
Humacyte's Symvess earns FDA approval as a first-in-class bioengineered vascular solution for urgent arterial injury repair ...
SYMVESS is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial ...
SYMVESS was used to repair many types of traumatic injuries ... we have an innovative technology for battlefield vascular injuries using a tissue engineered human arterial replacement that can ...
The U.S. Food and Drug Administration approved Symvess, the first acellular tissue engineered vessel indicated for use in ...
Humacyte (HUMA) stock climbs as FDA approves Symvess, its implantable vascular conduit for arterial injury. Read more here.
Bukayo Saka is set to miss several months of action through injury after the Arsenal winger underwent surgery.The 23-year-old ...
A breakthrough in life-saving medical technology has arrived. The U.S. Food and Drug Administration (FDA) has officially ...
A Phase I clinical trial has demonstrated the long-term safety of neural stem cell transplantation for chronic spinal cord ...
Explore the amazing power of heart regeneration. Discover how new research is changing the way we understand the human ...